These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 36169217)

  • 1. Targeted virtual opioid overdose education and naloxone distribution in overdose hotspots for older adults during COVID-19.
    Beiting KJ; Molony J; Ari M; Thompson K
    J Am Geriatr Soc; 2022 Nov; 70(11):E26-E29. PubMed ID: 36169217
    [No Abstract]   [Full Text] [Related]  

  • 2. Naloxone for Opioid Overdose: Comment.
    Pattullo GG
    Anesthesiology; 2024 Apr; 140(4):856. PubMed ID: 38335034
    [No Abstract]   [Full Text] [Related]  

  • 3. Naloxone for Opioid Overdose: Comment.
    Milas BL; Varon AJ
    Anesthesiology; 2024 Apr; 140(4):857. PubMed ID: 38335038
    [No Abstract]   [Full Text] [Related]  

  • 4. Opioid overdose knowledge among college students compared to experienced opioid users.
    Jones JD; Avila JR; Smith MK; Martinez S
    Drug Alcohol Rev; 2024 Jan; 43(1):343-346. PubMed ID: 37920901
    [No Abstract]   [Full Text] [Related]  

  • 5. Opioid overdose prevention education in Texas during the COVID-19 pandemic.
    Mathias CW; Cavazos DM; McGlothen-Bell K; Crawford AD; Flowers-Joseph B; Wang Z; Cleveland LM
    Harm Reduct J; 2023 Mar; 20(1):37. PubMed ID: 36964600
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Statewide Policy to Increase Provision of Take-Home Naloxone at Emergency Department Visits for Opioid Overdose, Rhode Island, 2018‒2019.
    Griffith J; Yorlets RR; Chambers LC; Davis CS; Wentz A; Beaudoin FL; Baird J; Samuels EA
    Am J Public Health; 2023 Apr; 113(4):372-377. PubMed ID: 36745856
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A medical student-led model for telephone-based opioid overdose education and naloxone distribution during the COVID-19 pandemic.
    Hughes TM; Kalicki A; Huxley-Reicher Z; Toribio W; Samuels DL; Weiss JJ; Herscher M; Wang L
    Subst Abus; 2022; 43(1):988-992. PubMed ID: 35435812
    [No Abstract]   [Full Text] [Related]  

  • 8. Disparities in opioid overdose survival and naloxone administration in Pennsylvania.
    Holmes LM; Rishworth A; King BH
    Drug Alcohol Depend; 2022 Sep; 238():109555. PubMed ID: 35810621
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Considerations for the design of overdose education and naloxone distribution interventions: results of a multi-stakeholder workshop.
    Sellen K; Markowitz B; Parsons JA; Leece P; Handford C; Goso N; Hopkins S; Klaiman M; Shahin R; Milos G; Wright A; Charles M; Morrison L; Strike C; Orkin A;
    BMC Public Health; 2023 May; 23(1):888. PubMed ID: 37189052
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Take-home Naloxone at Opioid Treatment Programs: A Lifesaver.
    Katzman JG; Bhatt S; Comerci GD
    J Addict Med; 2022 Nov-Dec 01; 16(6):619-621. PubMed ID: 35220332
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Buprenorphine and naloxone access in pharmacies within high overdose areas of Los Angeles during the COVID-19 pandemic.
    Dadiomov D; Bolshakova M; Mikhaeilyan M; Trotzky-Sirr R
    Harm Reduct J; 2022 Jun; 19(1):69. PubMed ID: 35768817
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intranasal Naloxone for Opioid Overdose.
    Taylor JL; Lasser KE
    JAMA; 2024 Jan; 331(3):250-251. PubMed ID: 38127361
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protecting Against Opioid Overdose: Naloxone Co-Prescribing.
    Nathan N
    Anesth Analg; 2022 Jul; 135(1):20. PubMed ID: 35709440
    [No Abstract]   [Full Text] [Related]  

  • 14. Optimizing naloxone distribution to prevent opioid overdose fatalities: results from piloting the Systems Analysis and Improvement Approach within syringe service programs.
    Patel SV; Wenger LD; Kral AH; Sherr K; Wagner AD; Davidson PJ; Lambdin BH
    BMC Health Serv Res; 2023 Mar; 23(1):278. PubMed ID: 36949494
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simulating the Simultaneous Impact of Medication for Opioid Use Disorder and Naloxone on Opioid Overdose Death in Eight New York Counties.
    Cerdá M; Hamilton AD; Hyder A; Rutherford C; Bobashev G; Epstein JM; Hatna E; Krawczyk N; El-Bassel N; Feaster DJ; Keyes KM
    Epidemiology; 2024 May; 35(3):418-429. PubMed ID: 38372618
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Piloting a statewide emergency department take-home naloxone program: Improving the quality of care for patients at risk of opioid overdose.
    Dora-Laskey A; Kellenberg J; Dahlem CH; English E; Gonzalez Walker M; Brummett CM; Kocher KE
    Acad Emerg Med; 2022 Apr; 29(4):442-455. PubMed ID: 34962682
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stigma by Association: To what Extent is the Attitude Toward Naloxone Affected by the Stigma of Opioid Use Disorder?
    Adeosun SO
    J Pharm Pract; 2023 Aug; 36(4):941-952. PubMed ID: 35505618
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Attitude changes following short-form opioid overdose video education: a pilot study.
    Galiher MV; Huffman M
    Harm Reduct J; 2022 Oct; 19(1):114. PubMed ID: 36241995
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Designing a public access naloxone program for public transportation stations.
    Kohli S; Garg J; Velasquez DE; Weiner SG
    Healthc (Amst); 2023 Jun; 11(2):100694. PubMed ID: 37247465
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting community-based naloxone distribution using opioid overdose death rates: A descriptive analysis of naloxone rescue kits and opioid overdose deaths in Massachusetts and Rhode Island.
    Zang X; Macmadu A; Krieger MS; Behrends CN; Green TC; Morgan JR; Murphy SM; Nolen S; Walley AY; Schackman BR; Marshall BD
    Int J Drug Policy; 2021 Dec; 98():103435. PubMed ID: 34482264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.